Evidence-Based Reviews

Treating bipolar mania in the outpatient setting: Risk vs reward

Author and Disclosure Information

 

References


Acknowledgement
The authors thank Peter Ash, MD, for carefully reviewing this manuscript and providing feedback.


Disclosures
Dr. Rakofsky receives research or grant support from Takeda. Dr. Dunlop receives research or grant support from Forest, GlaxoSmithKline, and Otsuka.

Pages

Recommended Reading

ADHD or bipolar disorder?
MDedge Psychiatry
Lurasidone monotherapy improves quality of life in bipolar I
MDedge Psychiatry
Dissociation found to mediate ketamine’s antidepressive effects
MDedge Psychiatry
For couples seeking to conceive, offer advice on reducing the risk of schizophrenia in their child
MDedge Psychiatry
Should lithium and ECT be used concurrently in geriatric patients?
MDedge Psychiatry
Telepsychiatry is a tool that we must exploit
MDedge Psychiatry
Severity of side effects key to choosing between lithium and quetiapine in bipolar I and II
MDedge Psychiatry
Cautions when prescribing lithium
MDedge Psychiatry
Monitoring calcium with lithium treatment
MDedge Psychiatry
Depressed, suicidal, and brittle in her bones
MDedge Psychiatry

Related Articles